Company Filing History:
Years Active: 1996-1998
Title: The Innovations of Hans Hermann Grunicke
Introduction
Hans Hermann Grunicke is a notable inventor based in Mils, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of combination therapies for cancer treatment. With a total of two patents to his name, Grunicke's work has the potential to impact the lives of many patients undergoing cytostatic therapy.
Latest Patents
Grunicke's latest patents include a method of determining pharmaceutical combination preparations for use. This invention provides a pharmaceutical combination preparation that contains at least two active materials, with one being an inhibitor of protein kinase C and the other having anti-neoplastic action. Additionally, he has developed a pharmaceutical composition preparation for use in inhibiting protein kinase C in mammals with tumor systems. This method involves administering a protein kinase C inhibitor to mammals undergoing cytostatic therapy.
Career Highlights
Grunicke is associated with Boehringer Mannheim GmbH, a company known for its innovative contributions to the pharmaceutical industry. His work at the company has allowed him to focus on developing effective treatments that can enhance patient outcomes.
Collaborations
Some of his notable coworkers include Dieter Herrmann and Johann Hofmann. Their collaboration has likely contributed to the advancements in research and development within their field.
Conclusion
Hans Hermann Grunicke's contributions to pharmaceutical innovations demonstrate his commitment to improving cancer treatment options. His patents reflect a deep understanding of the complexities involved in developing effective therapies.